Also trades as: JNH.V (TSXV) · $vol 0M
JNHMF OTC
Jack Nathan Medical Corp.
1W: +0.0%
1M: +0.0%
3M: -88.9%
YTD: -88.9%
1Y: -75.0%
3Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$9M
-54.5% ▼
5Y CAGR: +19.2%
Gross Profit
$7M
-49.1% ▼
5Y CAGR: +21.6%
Operating Income
-$2M
-7.6% ▼
Net Income
$7M
+212.5% ▲
EPS (Diluted)
$-0.03
+61.3% ▲
EBITDA
-$2M
+64.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4M | $10M | $15M | $19M | $9M |
| YoY Growth | +6.5% | +150.2% | +60.7% | +23.6% | -54.5% |
| Cost of Revenue | $74K | $3M | $4M | $5M | $1M |
| Gross Profit | $4M | $7M | $12M | $14M | $7M |
| Gross Margin | 98.1% | 71.8% | 76.3% | 75.6% | 84.7% |
| R&D Expenses | $102K | $546K | $237K | $0 | $0 |
| SG&A Expenses | $4M | $13M | $17M | $7M | $9M |
| Operating Expenses | $4M | $14M | $17M | $21M | $10M |
| Operating Income | -$1M | -$8M | -$7M | -$2M | -$2M |
| Operating Margin | -35.2% | -87.9% | -44.9% | -12.0% | -28.5% |
| Interest Expense | $36K | $182K | $410K | $0 | $22K |
| Income Before Tax | -$10M | -$8M | -$7M | -$2M | -$3M |
| Tax Expense | -$381K | -$218K | -$86K | $806K | $16K |
| Net Income | -$10M | -$8M | -$7M | -$7M | $7M |
| Net Margin | -257.3% | -81.0% | -45.7% | -34.7% | 85.7% |
| EPS (Diluted) | $-0.19 | $-0.09 | $-0.08 | $-0.08 | $-0.03 |
| EBITDA | -$10M | -$6M | -$4M | -$4M | -$2M |
| Shares Outstanding | 52M | 82M | 84M | 86M | 87M |